ir.inovio.comInovio Pharmaceuticals, Inc. - INVESTORS & MEDIA
ir.inovio.com Profile
Ir.inovio.com is a subdomain of inovio.com, which was created on 2000-02-19,making it 24 years ago.
Discover ir.inovio.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.inovio.com Information
| HomePage size: 120.186 KB |
| Page Load Time: 0.281107 Seconds |
| Website IP Address: 162.159.130.11 |
ir.inovio.com Similar Website
| Maryland Real Estate Investors Association - Maryland Real Estate Investors Association |
| Investor Relations :: CNS Pharmaceuticals, Inc. (CNSP) |
| Viridian Therapeutics, Inc. - Investors & Media |
| Western Midstream - Investors - Investors |
| Investors | Kidoz Inc. – Kidoz Inc. |
| OMNOVA Solutions - Investors - Investors |
| Investors :: Conatus Pharmaceuticals Inc. (CNAT) |
| Investors | Marathon Oil Corporation - Investors |
| Axalta Coating Systems - Investors - Investors Overview |
| Investors & Media | Ionis Pharmaceuticals, Inc. |
| Investors | Syndax Pharmaceuticals, Inc. |
| Connected Investors | Connect With Real Estate Investors |
| Investors | Fusion Pharmaceuticals - Overview |
| Lifeline Pharmaceuticals, LLC’s Login Page | Lifeline Pharmaceuticals, LLC |
| Investors - Toromont Industries Ltd. - Investors |
ir.inovio.com PopUrls
| Inovio Pharmaceuticals, Inc. - INVESTORS & MEDIA https://ir.inovio.com/investors-and-media/default.aspx |
| INOVIO Reports First Quarter 2022 Financial Results and Program ... https://ir.inovio.com/news-releases/news-releases-details/2022/INOVIO-Reports-First-Quarter-2022-Financial-Results-and-Program-Developments/default.as |
| INOVIO Reports Fourth Quarter and Full Year 2022 Financial Results and ... https://ir.inovio.com/news-releases/news-releases-details/2023/INOVIO-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Clinical-Highlig |
| INOVIO Announces Second Quarter 2023 Financial Results and Provides ... https://ir.inovio.com/news-releases/news-releases-details/2023/INOVIO-Announces-Second-Quarter-2023-Financial-Results-and-Provides-Strategic-Update/de |
| Inovio Pharmaceuticals, Inc. - INOVIO Highlights Key Updates on Phase 3 ... https://ir.inovio.com/news-releases/news-releases-details/2021/INOVIO-Highlights-Key-Updates-on-Phase-3-Program-for-VGX-3100-its-DNA-based-Immunothera |
| INOVIO Reports Fourth Quarter 2021 and Year-End Financial Results https://ir.inovio.com/news-releases/news-releases-details/2022/INOVIO-Reports-Fourth-Quarter-2021-and-Year-End-Financial-Results/default.aspx |
| Inovio Pharmaceuticals, Inc. - INOVIO Announces Strategy to Address ... https://ir.inovio.com/news-releases/news-releases-details/2021/INOVIO-Announces-Strategy-to-Address-Omicron-B.1.1.529-and-Future-SARS-CoV-2-Variants/d |
| Inovio Pharmaceuticals, Inc. - INOVIO Reports Financial Results and ... https://ir.inovio.com/news-releases/news-releases-details/2022/INOVIO-Reports-Financial-Results-and-Highlights-for-the-Third-Quarter-2022/default.aspx |
| INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024 https://ir.inovio.com/news-releases/news-releases-details/2024/INOVIO-to-Report-First-Quarter-2024-Financial-Results-on-May-13-2024/default.aspx |
| INVESTORS & MEDIA - Inovio Pharmaceuticals, Inc. https://ir.inovio.com/news-releases/default.aspx |
| SEC Filings - Investors & Media - INOVIO Pharmaceuticals https://ir.inovio.com/financials/default.aspx |
| INVESTORS & MEDIA - Inovio Pharmaceuticals, Inc. https://ir.inovio.com/faq/default.aspx |
| Analyst Coverage - Investors & Media - INOVIO Pharmaceuticals https://ir.inovio.com/analyst-coverage/default.aspx |
| INVESTORS & MEDIA - Inovio Pharmaceuticals, Inc. https://ir.inovio.com/financials/2024/default.aspx |
| INVESTORS & MEDIA - Inovio Pharmaceuticals, Inc. https://ir.inovio.com/media-kit/default.aspx |
ir.inovio.com Httpheader
| Date: Tue, 14 May 2024 21:51:00 GMT |
| Content-Type: text/html; charset=utf-8 |
| Transfer-Encoding: chunked |
| Connection: keep-alive |
| CF-Ray: 883e1b6d2b3caab2-SJC |
| CF-Cache-Status: REVALIDATED |
| Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 |
| Vary: Accept-Encoding |
| X-Content-Type-Options: nosniff |
| X-XSS-Protection: 0 |
| Server: cloudflare |
ir.inovio.com Meta Info
| content="text/html; charset=utf-8" http-equiv="Content-type"/ |
| content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/ |
| content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
| content="width=device-width, initial-scale=1" name="viewport"/ |
| content="qYD_SOjlfchQy7wWVWLh5CGddvPcsAn8v1B1Tg4n-4c" name="google-site-verification"/ |
ir.inovio.com Html To Plain Text
Inovio Pharmaceuticals, Inc. - INVESTORS & MEDIA For Patients: Clinical Trials Publications Careers Contact UsToggle navigation Investors & Media Events & Presentations Stock Information News Releases Financials SEC filings Quarterly & Annual Reports IRS Tax Form 8937 Analyst Coverage Corporate Governance Governance Documents Board Committee Composition Shareholder Services Derivative Settlement Email Alerts RSS Feeds FAQ - Frequently Asked questions About InovioPurpose, Mission and Values Inovio FirstsLeadership Board of DirectorsScientific Advisory BoardCEO CornerPartnerships DNA Medicines TechnologyOptimized Plasmid Design and Delivery DNA Medicines Explained Technology Advances Pioneering dMAb TM Science Our Focus: Serving PatientsEmpowering Human Immunity HPV-Associated Diseases Immuno-Oncology Infectious Diseases Covid-19DNA Medicines PipelineInvestors & Media Events & Presentations Stock Information News Releases Financials SEC filings Quarterly & Annual Reports IRS Tax Form 8937 Analyst Coverage Corporate Governance Governance Documents Board Committee Composition Shareholder Services Derivative Settlement Email Alerts RSS Feeds FAQ - Frequently Asked questions About Inovio Mission and Values Inovio Firsts Leadership Board of Directors Scientific Advisory Board CEO Corner Partnerships DNA Medicine Technology Optimized Plasmid Design and Delivery DNA Medicines Explained Technology Advances Pioneering dMAb TM Science Our Focus: Serving Patients Empowering Human Immunity HPV-Associated Diseases Immuno-Oncology Infectious Diseases Covid-19 DNA Medicine Pipeline For Patients Publications Careers Contact Us INVESTORS & MEDIA INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Latest corporate presentation Latest investor presentationLatest corporate fact sheet Latest publications Latest publications Latest quarterly earnings Latest quarterly earnings Annual report Presentations Events Upcoming EventsStock Information View stock quote News Releases All News Releases Quick Links SEC Filings Analyst Coverage Investor Faq Corporate Governance Subscribe for updates from inovio Register to receive email alerts for INOVIO press releases Email Alerts To opt-in for investor email alerts, please enter your email address in the field and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At INOVIO, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section. If you experience any issues with this process, please contact us for further assistance. By providing your email address, you are providing consent to INOVIO to send you the requested Investor Email Alert updates. * Required Mailing Lists * Press Release Events SEC Filing End of Day Stock Quote Email Address * Enter the code shown above. * Unsubscribe Email Alert Sign Up Confirmation About Inovio DNA Medicines Technology Our Focus: Serving PatientsDNA Medicines Pipeline Investors & Media For Patients Publications Careers Contact Us Safe Harbor Statement Expanded Access Privacy Policy Terms & Conditions© Copyright INOVIO Pharmaceuticals. All rights reserved Powered By Q4 Inc. 5.122.0.3 (opens in new window) Opens in new...
ir.inovio.com Whois
Domain Name: INOVIO.COM Registry Domain ID: 20187221_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2024-02-15T06:36:18Z Creation Date: 2000-02-19T08:50:47Z Registry Expiry Date: 2025-02-19T08:50:47Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited Name Server: DNS1.CSCDNS.NET Name Server: DNS2.CSCDNS.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T21:27:25Z <<<